These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 7788918)

  • 1. Results of the international study of the implantable pacemaker cardioverter-defibrillator. A comparison of epicardial and endocardial lead systems. The Pacemaker-Cardioverter-Defibrillator Investigators.
    Zipes DP; Roberts D
    Circulation; 1995 Jul; 92(1):59-65. PubMed ID: 7788918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defibrillation thresholds and perioperative mortality associated with endocardial and epicardial defibrillation lead systems. The PCD investigators and participating institutions.
    Saksena S
    Pacing Clin Electrophysiol; 1993 Jan; 16(1 Pt 2):202-7. PubMed ID: 7681572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome of patients with malignant ventricular tachyarrhythmias and a multiprogrammable implantable cardioverter-defibrillator implanted with or without thoracotomy: an international multicenter study. PCD Investigator Group.
    J Am Coll Cardiol; 1994 Jun; 23(7):1521-30. PubMed ID: 8195508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [10 years of therapy with implantable defibrillators--observation in 353 patients].
    Trappe HJ; Wenzlaff P; Klein H; Pfitzner P; Fieguth HG; Kielblock B; Lichtlen PR
    Z Kardiol; 1995 Mar; 84(3):222-31. PubMed ID: 7732715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of ICD lead related complications during long-term follow-up: comparison of epicardial and endocardial electrode systems.
    Korte T; Jung W; Spehl S; Wolpert C; Moosdorf R; Manz M; Lüderitz B
    Pacing Clin Electrophysiol; 1995 Nov; 18(11):2053-61. PubMed ID: 8552520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of ventricular tachyarrhythmias with an implantable pacemaker-cardioverter-defibrillator].
    Ohm OJ; Faerestrand S; Engedal H; Hegbom F; Stangeland L; Hoff PI
    Tidsskr Nor Laegeforen; 1993 Jan; 113(2):182-9. PubMed ID: 8430397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pacemaker and implantable cardioverter-defibrillator use in a US myotonic dystrophy type 1 population.
    Bhakta D; Shen C; Kron J; Epstein AE; Pascuzzi RM; Groh WJ
    J Cardiovasc Electrophysiol; 2011 Dec; 22(12):1369-75. PubMed ID: 22035077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
    Bardy GH; Yee R; Jung W
    J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P
    JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shock occurrence and survival in 241 patients with implantable cardioverter-defibrillator therapy.
    Grimm W; Flores BT; Marchlinski FE
    Circulation; 1993 Jun; 87(6):1880-8. PubMed ID: 8504500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatial and temporal heterogeneity of depolarization and repolarization may complicate implantable cardioverter defibrillator therapy in Brugada syndrome.
    Stix G; Bella PD; Carbucicchio C; Schmidinger H
    J Cardiovasc Electrophysiol; 2000 May; 11(5):516-21. PubMed ID: 10826930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable cardioverter-defibrillator: present and future indications.
    Block M; Scheld H; Breithardt G
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():141-7. PubMed ID: 8734176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A completely subcutaneous implantable cardioverter defibrillator system functioning simultaneously with an endocardial implantable cardioverter defibrillator programmed as pacemaker.
    van Opstal J; Geskes G; Debie L
    Europace; 2011 Jan; 13(1):141-2. PubMed ID: 20587539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality benefits and the implantable cardioverter-defibrillator.
    Sweeney MO; Ruskin JN
    Circulation; 1994 Apr; 89(4):1851-8. PubMed ID: 8149550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Defibrillator therapy 1997. Prerequisites--results--prospects].
    Trappe HJ
    Med Klin (Munich); 1997 Jul; 92(7):415-20. PubMed ID: 9324627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable cardioverter-defibrillator programming and electrical storm: Results of the OBSERVational registry On long-term outcome of ICD patients (OBSERVO-ICD).
    Guerra F; Palmisano P; Dell'Era G; Ziacchi M; Ammendola E; Bonelli P; Patani F; Cupido C; Devecchi C; Accogli M; Occhetta E; Santangelo L; Biffi M; Boriani G; Capucci A;
    Heart Rhythm; 2016 Oct; 13(10):1987-92. PubMed ID: 27291511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable Cardioverter Defibrillator Therapy.
    Hodgkinson KA; Howes AJ; Boland P; Shen XS; Stuckless S; Young TL; Curtis F; Collier A; Parfrey PS; Connors SP
    Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):. PubMed ID: 26966288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventricular tachycardia/fibrillation early after defibrillator implantation in patients with hypertrophic cardiomyopathy is explained by a high-risk subgroup of patients.
    Alsheikh-Ali AA; Link MS; Semsarian C; Shen WK; Estes NA; Maron MS; Haas TS; Formisano F; Boriani G; Spirito P; Maron BJ
    Heart Rhythm; 2013 Feb; 10(2):214-8. PubMed ID: 23041573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
    Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
    Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the implantable cardioverter-defibrillator on rehospitalizations.
    Valenti R; Schlåpfer J; Fromer M; Fischer A; Kappenberger L
    Eur Heart J; 1996 Oct; 17(10):1565-71. PubMed ID: 8909915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.